CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin. (Q51815081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

Monika C Brunner-Weinzierl

21 January 2020

author

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Johannes K Hegel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Karin Knieke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Paula Kolar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Steven L Reiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

883-893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19224637%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

cites work

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

T-cell regulation by CD28 and CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

CTLA-4: new insights into its biological function and use in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Recent developments in the transcriptional regulation of cytolytic effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Eomesodermin, a key early gene in Xenopus mesoderm differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Eomesodermin is required for mouse trophoblast development and mesoderm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Expression of the transcription factor cKrox in peripheral CD8 T cells reveals substantial postthymic plasticity in CD4-CD8 lineage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

The reverse stop-signal model for CTLA4 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

Reversal of the TCR stop signal by CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

The tyrosine phosphatase SHP-2 regulates differentiation and apoptosis of individual primary T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770

inferred from DOI database lookup

7 January 2021

based on heuristic

Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838770